Live tape
Top 8, mentions 7d14,338NVDA4,854 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,736 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,106 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK861 mentions▲ +0.05

Equity · Healthcare

DNLI

NASDAQ

Denali Therapeutics (DNLI)

23.43 USD −0.95% vs prior close
Denali Therapeutics Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
3.8B USD
Revenue, year to Dec 2025
0 USD
EPS, diluted, year to Dec 2025
−2.97 USD
52-week range
13 USD – 27 USD
Avg volume
481.7K

as of Jul 23, 2026

Have Denali Therapeutics (DNLI) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Denali Therapeutics insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Dec 2025.

Form 4, 90 days to 10 Nov 2026, newest reported trade 4 Sep 2026

0buys
3sells
$364Knet sold
1other filings
Have Denali Therapeutics (DNLI) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
04 Sep 2026Chin Peter ScottChief Medical OfficerSell1,65437K USD
02 Sep 2026Thornberry NancyDirectorSell11,439262K USD
01 Sep 2026Schuth Alexander O.COFO and SecretarySell2,76865K USD
Sold3 open-market sales15,861$364K
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Denali Therapeutics (DNLI) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
12 Aug 2026Watts Ryan J.President and CEOGift32,220

Which funds hold Denali Therapeutics (DNLI)?

1 of the 45 institutional funds we track reported a Denali Therapeutics position for the quarter ended 30 Sep 2026 — a combined 50.9M USD; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold Denali Therapeutics (DNLI)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementHeld (±25%)2,460,54550.9M USD+1.9%

What has been filed or recorded for Denali Therapeutics (DNLI)?

The filings we hold for Denali Therapeutics, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Denali Therapeutics (DNLI)?
And
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 0.37 USD
30 Sep 2026FinancialsTotal assets1.3B USDat period end
30 Sep 2026FinancialsTotal equity926.4M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.68 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.69 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −2.97 USD
31 Dec 2025FinancialsRevenue0 USDfiscal year
31 Dec 2025FinancialsNet income−512.5M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−2.97 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.74 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.72 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.78 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −2.57 USD

What do people ask about Denali Therapeutics (DNLI)?

From live data
What is Denali Therapeutics’ market cap?3.8B

Denali Therapeutics is worth 3.8B USD by market value as of 23 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is Denali Therapeutics’ revenue?0

Denali Therapeutics reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Denali Therapeutics insiders bought or sold shares recently?3 sales

In the 90 days to 10 Nov 2026, Denali Therapeutics insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Dec 2025. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

Which funds own Denali Therapeutics?1 of 45

1 of the 45 funds we track reported a Denali Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

When did Denali Therapeutics last report earnings?0.37

Denali Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.37 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  6. SEC EDGARreported earnings figures and scheduled report dates
  7. SEC EDGARValuation computed from SEC EDGAR filings